The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (21 analysts) rates it buy, with a mean price target of $55.
BILL Holdings, Inc.
BILL · the NYSE · USD · Market cap $4.8B · 2,364 employees
BILL Holdings, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-08-26
Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
BILL Holdings, Inc. holds its Markdown at $48.11. The statistical read favours the sellers, held for 16 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 16 days |
| Price at the screen | $48.11 |
| Valuation | N/A trailing · 11.05 forward price to earnings |
| Values screen | FAIL · score 64.7 |
| Beta | 1.09 |
Five Screens, Shown in Full
Does not pass. Revenue purity
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.62% | Below 33% | Interest-bearing debt is just 17.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 11.73% | Below 33% | Cash held in interest-bearing accounts and securities is 11.7% of assets, under the one-third limit. | Pass |
| Receivables | 10.64% | Below 49% | Money owed to the company is 10.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 6.22% | Below 5% | 6.2% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. A 38.6% margin of safety to the base estimate.
Third-party analyst targets: 20 covering, consensus Buy. The average target sits +17% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSmall business payments tool shows zero profits
Every time a small firm pays a supplier or chases an invoice the software sits in the middle, yet BILL Holdings still posts a zero profit margin and zero return on equity. Revenue growth has slowed to 14 percent while the forward multiple sits at 13.3 times, numbers that fail to clear even a modest hurdle for a business whose moat remains unknown.
We pass because the margin of safety on paper does not offset the lack of actual earnings power or competitive edge, despite an ethical screen that clears. Analyst targets hover near 52 dollars but offer no buffer once the current lack of returns is priced in.
Risk sits in execution and competition from larger platforms that already serve the same customers, with currency and adoption swings adding further uncertainty in a market that rewards scale over features. Analysis, not advice.
| Forward P/E | 11.1xfairly priced for its growth rate |
| EPS, trailing | -0.11 |
| EPS, forward | 4.35 |
| Revenue growth | +13.8%steady growth |
| Profit margin | -0.7%currently unprofitable |
| Return on equity | -0.3%not currently earning a positive return on equity |
| FCF yield | 4.65% |
| Debt to equity | 0.54moderate, manageable leverage |
| Current ratio | 1.51healthy short-term liquidity |
| Beta | 1.09moves a little more than the market |
| Short interest, float | 0.14% |
| 52-week range | 31.41 - 57.21 |
| Market cap | $4.8B |
| Employees | 2,364 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBILL trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 24.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (21 analysts) rates it buy, with a mean price target of $55.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 29%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (21 analysts) rates it buy, with a mean price target of $55.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (65). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Scott Peters | Democrat | sell | 100K–250K |
| 7 May2026 | Scott Peters | Democrat | sell | 15K–50K |
| 6 Aug2026 | Steve Cohen | Democrat | buy | 100K–250K |
| 6 Aug2026 | Steve Cohen | Democrat | buy | 100K–250K |
| 4 May2026 | Steve Cohen | Democrat | buy | 50K–100K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $41.50 | -22.0% | · | $780 | -22.0% |
| 2 months | $34.71 | -6.8% | · | $932 | -6.8% |
| 3 months | $39.65 | -18.4% | · | $816 | -18.4% |
| 6 months | $54.96 | -41.1% | · | $589 | -41.1% |
| 1 year | $45.37 | -28.7% | · | $713 | -28.7% |
| 2 years | $52.05 | -37.8% | · | $622 | -37.8% |
| 3 years | $115.26 | -71.9% | · | $281 | -71.9% |
| 5 years | $157.34 | -79.4% | · | $206 | -79.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BILL does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.